192 related articles for article (PubMed ID: 25657580)
1. Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies.
Wang P; Li J; Qiu S; Wen H; Du J
Neuropsychiatr Dis Treat; 2015; 11():59-66. PubMed ID: 25657580
[TBL] [Abstract][Full Text] [Related]
2. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
4. Reproductive factors and risk of Parkinson's disease in women: A meta-analysis of observational studies.
Lv M; Zhang Y; Chen GC; Li G; Rui Y; Qin L; Wan Z
Behav Brain Res; 2017 Sep; 335():103-110. PubMed ID: 28743601
[TBL] [Abstract][Full Text] [Related]
5. The association between different hormone replacement therapy use and the incidence of lung cancer: a systematic review and meta-analysis.
Wen H; Lin X; Sun D
J Thorac Dis; 2022 Feb; 14(2):381-395. PubMed ID: 35280481
[TBL] [Abstract][Full Text] [Related]
6. Association between coffee drinking and endometrial cancer risk: A meta-analysis.
Gao Y; Zhai P; Jiang F; Zhou F; Wang X
J Obstet Gynaecol Res; 2022 Mar; 48(3):774-795. PubMed ID: 35048465
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease and risk of Parkinson's disease: evidence from a meta-analysis of 14 studies involving more than 13.4 million individuals.
Li HX; Zhang C; Zhang K; Liu YZ; Peng XX; Zong Q
Front Med (Lausanne); 2023; 10():1137366. PubMed ID: 37153103
[TBL] [Abstract][Full Text] [Related]
8. Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies.
Qi ZY; Shao C; Zhang X; Hui GZ; Wang Z
PLoS One; 2013; 8(7):e68695. PubMed ID: 23874728
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and lung cancer risk in women: a meta-analysis of cohort studies: Hormone replacement therapy and lung cancer risk.
Jin C; Lang B
Medicine (Baltimore); 2019 Dec; 98(51):e17532. PubMed ID: 31860945
[TBL] [Abstract][Full Text] [Related]
10. Association between Statin Use and Risk of Parkinson's Disease: Evidence from 18 Observational Studies Comprising 3.7 Million Individuals.
Wu CC; Islam MM; Lee AJ; Su CH; Weng YC; Yeh CY; Lee HH; Lin MC
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629248
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapies, oral contraceptives, reproductive factors and colorectal adenoma risk: a systematic review and dose-response meta-analysis of observational studies.
Song J; Jin Z; Han H; Li M; Guo Y; Guo H; Guo W; He J
Colorectal Dis; 2019 Jul; 21(7):748-759. PubMed ID: 30748083
[TBL] [Abstract][Full Text] [Related]
12. Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies.
Xiao Y; Xia J; Li L; Ke Y; Cheng J; Xie Y; Chu W; Cheung P; Kim JH; Colditz GA; Tamimi RM; Su X
Breast Cancer Res; 2019 Jan; 21(1):16. PubMed ID: 30696460
[TBL] [Abstract][Full Text] [Related]
13. Statin use and risk of Parkinson's disease: A meta-analysis.
Sheng Z; Jia X; Kang M
Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
[TBL] [Abstract][Full Text] [Related]
14. The Relationship Between Hormone Replacement Therapy and Risk of Kidney Cancer in Women: A Meta-Analysis.
Zhang X; Du Y; Tan X; Wang H; Li Y; Zhang Z; Wang A
Cancer Control; 2020; 27(2):1073274820930194. PubMed ID: 32668959
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Association between Statin Use and the Risk of Parkinson's Disease: A Meta-Analysis of Observational Studies.
Poly TN; Islam MM; Walther BA; Yang HC; Nguyen PA; Huang CW; Shabbir SA; Li YJ
Neuroepidemiology; 2017; 49(3-4):142-151. PubMed ID: 29145202
[TBL] [Abstract][Full Text] [Related]
16. Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis.
Liu Y; Ma L; Yang X; Bie J; Li D; Sun C; Zhang J; Meng Y; Lin J
Front Endocrinol (Lausanne); 2019; 10():801. PubMed ID: 31849838
[No Abstract] [Full Text] [Related]
17. Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis.
Bai S; Song Y; Huang X; Peng L; Jia J; Liu Y; Lu H
PLoS One; 2016; 11(3):e0152564. PubMed ID: 27019096
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus, prediabetes and the risk of Parkinson's disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases.
Aune D; Schlesinger S; Mahamat-Saleh Y; Zheng B; Udeh-Momoh CT; Middleton LT
Eur J Epidemiol; 2023 Jun; 38(6):591-604. PubMed ID: 37185794
[TBL] [Abstract][Full Text] [Related]
19. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
[TBL] [Abstract][Full Text] [Related]
20. Association of hormone replacement therapy with risk of gastric cancer: a systematic review and meta-analysis.
Jang YC; Leung CY; Huang HL
Sci Rep; 2022 Jul; 12(1):12997. PubMed ID: 35906381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
